In recent years, the interplay between metabolic factors and cancer outcomes has attracted growing scientific interest, revealing complex mechanisms that influence patient survival beyond traditional oncological parameters. A groundbreaking new study from researchers at The First Hospital of Lanzhou University sheds light on a crucial yet under-explored aspect of gastric cancer prognosis: the role of postoperative blood glucose levels in non-diabetic patients, and how this intersects with body composition to impact overall survival.
Gastric cancer remains one of the most formidable challenges in oncology, characterized by high mortality rates worldwide despite advances in surgical and chemotherapeutic approaches. Surgical intervention is often the cornerstone of curative treatment; yet, the postoperative period introduces a vulnerable window where metabolic complications can critically influence recovery trajectories. Hyperglycemia, commonly observed after surgery, has been traditionally studied in diabetic populations, but its significance in non-diabetic patients has remained largely ambiguous — until now.
This pioneering study evaluated data from 349 non-diabetic gastric cancer patients who underwent curative surgery between March 2017 and June 2021. Researchers stratified these patients based on postoperative blood glucose readings and meticulously analyzed how these variations correlated with overall survival. The study’s multifaceted approach integrated advanced statistical models including Cox regression and mediation analyses, probing beyond correlation to understand causal pathways linking metabolic and compositional parameters to clinical outcomes.
.adsslot_xdTkypC7Kl{width:728px !important;height:90px !important;}
@media(max-width:1199px){ .adsslot_xdTkypC7Kl{width:468px !important;height:60px !important;}
}
@media(max-width:767px){ .adsslot_xdTkypC7Kl{width:320px !important;height:50px !important;}
}
ADVERTISEMENT
Among the key findings, postoperative hyperglycemia emerged as an independent predictor of diminished overall survival, alongside well-established factors such as age over 65, pTNM staging, and neoadjuvant chemotherapy. These findings challenge the long-held assumption that blood glucose regulation is chiefly a concern for diabetic patients, exposing a critical vulnerability in the non-diabetic subset that has been overlooked in clinical monitoring protocols.
Crucially, the study uncovered that preoperative body composition—specifically metrics such as visceral adipose tissue index (VATI), subcutaneous adipose tissue index, and skeletal muscle density—had significant associations with postoperative blood glucose levels. This nexus suggests a biological interplay where variations in fat distribution and muscle composition influence metabolic responses to surgical stress, thereby affecting glycemic control postoperatively.
Detailed correlation analysis further substantiated that higher preoperative visceral adipose tissue is linked to elevated postoperative blood glucose. This correlation, however, bore a paradoxical relationship with survival: while increased VATI was previously associated with better survival outcomes, this benefit was partially negated by the detrimental mediation through postoperative hyperglycemia. Through mediation analysis, the researchers quantified this negative mediating effect at -12.9%, illustrating a sizable attenuation of survival benefit due to glycemic disturbances following surgery.
The mechanistic insights from this study resonate with emerging evidence about the role of inflammatory and metabolic dysregulation in cancer progression. Elevated glucose levels post-surgery may create a microenvironment conducive to tumor recurrence or impaired tissue healing, exacerbating the already precarious immune and metabolic balance in cancer patients. This research thus calls attention to the need for integrating metabolic monitoring and intervention as part of comprehensive postoperative care—even in those without a formal diagnosis of diabetes.
Furthermore, the work highlighted that other hematological parameters such as hemoglobin and total protein levels also influenced postoperative blood glucose dynamics. These findings suggest that nutritional and systemic inflammatory status may together modulate perioperative glycemic responses, providing a holistic framework for understanding patient vulnerability beyond isolated glucose measures.
The implications for clinical practice are profound. Current protocols often prioritize glycemic control primarily in diabetic patients; this study advocates for a paradigm shift, recommending diligent monitoring and proactive management of blood glucose in all gastric cancer patients undergoing surgery. Such an approach could involve tailored nutritional support, vigilant glucose surveillance, and potentially pharmacologic interventions aimed at stabilizing glucose levels during the critical postoperative window.
Concurrently, the study underscores the prognostic value of preoperative body composition assessment in stratifying patients not only by traditional oncologic risk but also by their metabolic resilience. Tools such as CT-based quantification of adipose tissue and muscle density could become indispensable in personalized perioperative planning, guiding interventions that optimize metabolic homeostasis and ultimately improve survival.
This research also opens new avenues for exploring the molecular underpinnings linking adiposity, muscle quality, and glucose metabolism with cancer biology. Future studies might investigate whether targeted therapies addressing metabolic pathways could synergize with surgical and chemotherapeutic modalities, forging a comprehensive strategy against gastric cancer lethality.
Moreover, the demonstrated mediating effect of postoperative blood glucose provides a template for similar investigations in other cancer types where metabolic derangements are prevalent, potentially broadening the scope of metabolic oncology as a multidisciplinary field.
The robustness of the study was enhanced by the application of bootstrap methods in mediation testing, strengthening the confidence in the identified indirect pathways. Such methodological rigor sets a benchmark for subsequent clinical research aiming to dissect complex interactions between patient physiology and oncological outcomes.
Industry experts have noted that the integration of metabolic parameters into cancer prognosis represents a frontier in precision medicine, where tailoring treatments based on a patient’s unique biochemical landscape can drive superior results. The findings presented here have the potential to catalyze a reevaluation of guidelines and inspire incorporation of metabolic biomarkers into routine oncological workflows.
In summary, this research compellingly demonstrates that postoperative hyperglycemia significantly undermines the survival advantages conferred by favorable body composition in non-diabetic gastric cancer patients. This nuanced finding not only enhances our understanding of gastric cancer biology but also prompts immediate clinical considerations to improve patient management.
As the landscape of cancer treatment evolves, interdisciplinary approaches embracing metabolism, nutrition, and surgery will be vital to unlocking new survival benefits. This study from The First Hospital of Lanzhou University is a groundbreaking step in that direction, reminding clinicians and researchers alike of the critical interplay between metabolic health and oncological success.
The opportunity now lies in translating these insights into actionable clinical protocols that ensure all gastric cancer patients receive comprehensive postoperative care encompassing rigorous glycemic control, irrespective of diabetic status.
Such advancements hold promise not only for improving survival rates but also for enhancing the quality of life and long-term health outcomes in this vulnerable patient population, marking a new dawn in gastric cancer management.
Subject of Research: The impact of postoperative blood glucose on overall survival and its mediating role between body composition and survival outcomes in non-diabetic gastric cancer patients.
Article Title: The mediating role of postoperative blood glucose in the relationship between body composition and overall survival in non-diabetic gastric cancer patients.
Article References:
Lan, N., Lai, M., Gao, Y. et al. The mediating role of postoperative blood glucose in the relationship between body composition and overall survival in non-diabetic gastric cancer patients. BMC Cancer 25, 995 (2025). https://doi.org/10.1186/s12885-025-14401-8
Image Credits: Scienmag.com
DOI: https://doi.org/10.1186/s12885-025-14401-8
Tags: body composition and survivalcancer treatment and recoverycurative surgery outcomesgastric cancer mortality ratesgastric cancer prognosishyperglycemia after surgerymetabolic factors in cancernon-diabetic patient outcomespatient survival and metabolismpost-surgery blood sugar levelspostoperative complications in oncologystatistical analysis in medical research
